LAW.coLAW.co

In re ROSUVASTATIN CALCIUM PATENT LITIGATION. Astrazeneca UK Limited, IPR Pharmaceuticals Inc., and Shionogi Seiyaku Kabushiki Kaisha, Plaintiffs-Appellees, v. Aurobindo Pharma Limited, Defendant-Appellant, and Mylan Pharmaceuticals Inc., Defendant-Appellant, and Apotex Corp., Defendant-Appellant, and Cobalt Pharmaceuticals Inc. and Cobalt Laboratories Inc., Defendants-Appellants, and Sun Pharmaceutical Industries, Ltd., Defendant-Appellant, and Teva Pharmaceuticals USA, Inc., Defendant-Appellant, and PAR Pharmaceutical, Inc., Defendant-Appellant, and Sandoz, Inc., Defendant

United States Court of Appeals for the Federal Circuit2011-03-24No. Nos. 2010-1460, 2010-1461, 2010-1462, 2010-1463, 2010-1464, 2010-1465, 2010-1466, 2010-1467, 2010-1468, 2010-1469, 2010-1470, 2010-1471, 2010-1472, 2010-1473
413 F. App'x 288

Authorities cited

No cited authorities resolved to law.co cases yet.

Opinion

majority opinion

MOTION

ORDER

Apotex Corp. moves for separate oral argument with respect to an issue in these appeals.

Upon consideration thereof,

It Is Ordered That:

The motion is deferred for consideration by the merits panel assigned to hear this case. Copies of this order, the motion and any response shall be transmitted to the merits panel.